Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease

Nancy Khov, Amol Sharma, Thomas R. Riley

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. While the American Association for the Study of Liver Diseases guidelines define NAFLD as hepatic steatosis detected either on histology or imaging without a secondary cause of abnormal hepatic fat accumulation, no imaging modality is recommended as standard of care for screening or diagnosis. Bedside ultrasound has been evaluated as a non-invasive method of diagnosing NAFLD with the presence of characteristic sonographic findings. Prior studies suggest characteristic sonographic findings for NAFLD include bright hepatic echoes, increased hepatorenal echogenicity, vascular blurring of portal or hepatic vein and subcutaneous tissue thickness. These sonographic characteristics have not been shown to aid bedside clinicians easily identify potential cases of NAFLD. While sonographic findings such as attenuation of image, diffuse echogenicity, uniform heterogeneous liver, thick subcutaneous depth, and enlarged liver filling of the entire field could be identified by clinicians from bedside ultrasound. The accessibility, ease of use, and low-side effect profile of ultrasound make bedside ultrasound an appealing imaging modality in the detection of hepatic steatosis. When used with appropriate clinical risk factors and steatosis involves greater than 33% of the liver, ultrasound can reliably diagnose NAFLD. Despite the ability of ultrasound in detecting moderate hepatic steatosis, it cannot replace liver biopsy in staging the degree of fibrosis. The purpose of this review is to examine the diagnostic accuracy, utility, and limitations of ultrasound in the diagnosis of NAFLD and its potential use by clinicians in routine practices.

Original languageEnglish (US)
Pages (from-to)6821-6825
Number of pages5
JournalWorld Journal of Gastroenterology
Volume20
Issue number22
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Liver
Hepatic Veins
Hepatomegaly
Non-alcoholic Fatty Liver Disease
Subcutaneous Tissue
Standard of Care
Portal Vein
Blood Vessels
Liver Diseases
Ultrasonography
Histology
Fibrosis
Fats
Guidelines
Biopsy

Keywords

  • Bedside ultrasound
  • Liver biopsy
  • Liver cirrhosis
  • Liver disease
  • Liver fibrosis
  • Non-alcoholic fatty liver disease
  • Non-alcoholic steatohepatitis
  • Steatosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. / Khov, Nancy; Sharma, Amol; Riley, Thomas R.

In: World Journal of Gastroenterology, Vol. 20, No. 22, 01.01.2014, p. 6821-6825.

Research output: Contribution to journalReview article

@article{b49d1b72ca3e4810808fea93bab52091,
title = "Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease",
abstract = "Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. While the American Association for the Study of Liver Diseases guidelines define NAFLD as hepatic steatosis detected either on histology or imaging without a secondary cause of abnormal hepatic fat accumulation, no imaging modality is recommended as standard of care for screening or diagnosis. Bedside ultrasound has been evaluated as a non-invasive method of diagnosing NAFLD with the presence of characteristic sonographic findings. Prior studies suggest characteristic sonographic findings for NAFLD include bright hepatic echoes, increased hepatorenal echogenicity, vascular blurring of portal or hepatic vein and subcutaneous tissue thickness. These sonographic characteristics have not been shown to aid bedside clinicians easily identify potential cases of NAFLD. While sonographic findings such as attenuation of image, diffuse echogenicity, uniform heterogeneous liver, thick subcutaneous depth, and enlarged liver filling of the entire field could be identified by clinicians from bedside ultrasound. The accessibility, ease of use, and low-side effect profile of ultrasound make bedside ultrasound an appealing imaging modality in the detection of hepatic steatosis. When used with appropriate clinical risk factors and steatosis involves greater than 33{\%} of the liver, ultrasound can reliably diagnose NAFLD. Despite the ability of ultrasound in detecting moderate hepatic steatosis, it cannot replace liver biopsy in staging the degree of fibrosis. The purpose of this review is to examine the diagnostic accuracy, utility, and limitations of ultrasound in the diagnosis of NAFLD and its potential use by clinicians in routine practices.",
keywords = "Bedside ultrasound, Liver biopsy, Liver cirrhosis, Liver disease, Liver fibrosis, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis, Steatosis",
author = "Nancy Khov and Amol Sharma and Riley, {Thomas R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.3748/wjg.v20.i22.6821",
language = "English (US)",
volume = "20",
pages = "6821--6825",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "22",

}

TY - JOUR

T1 - Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease

AU - Khov, Nancy

AU - Sharma, Amol

AU - Riley, Thomas R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. While the American Association for the Study of Liver Diseases guidelines define NAFLD as hepatic steatosis detected either on histology or imaging without a secondary cause of abnormal hepatic fat accumulation, no imaging modality is recommended as standard of care for screening or diagnosis. Bedside ultrasound has been evaluated as a non-invasive method of diagnosing NAFLD with the presence of characteristic sonographic findings. Prior studies suggest characteristic sonographic findings for NAFLD include bright hepatic echoes, increased hepatorenal echogenicity, vascular blurring of portal or hepatic vein and subcutaneous tissue thickness. These sonographic characteristics have not been shown to aid bedside clinicians easily identify potential cases of NAFLD. While sonographic findings such as attenuation of image, diffuse echogenicity, uniform heterogeneous liver, thick subcutaneous depth, and enlarged liver filling of the entire field could be identified by clinicians from bedside ultrasound. The accessibility, ease of use, and low-side effect profile of ultrasound make bedside ultrasound an appealing imaging modality in the detection of hepatic steatosis. When used with appropriate clinical risk factors and steatosis involves greater than 33% of the liver, ultrasound can reliably diagnose NAFLD. Despite the ability of ultrasound in detecting moderate hepatic steatosis, it cannot replace liver biopsy in staging the degree of fibrosis. The purpose of this review is to examine the diagnostic accuracy, utility, and limitations of ultrasound in the diagnosis of NAFLD and its potential use by clinicians in routine practices.

AB - Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. While the American Association for the Study of Liver Diseases guidelines define NAFLD as hepatic steatosis detected either on histology or imaging without a secondary cause of abnormal hepatic fat accumulation, no imaging modality is recommended as standard of care for screening or diagnosis. Bedside ultrasound has been evaluated as a non-invasive method of diagnosing NAFLD with the presence of characteristic sonographic findings. Prior studies suggest characteristic sonographic findings for NAFLD include bright hepatic echoes, increased hepatorenal echogenicity, vascular blurring of portal or hepatic vein and subcutaneous tissue thickness. These sonographic characteristics have not been shown to aid bedside clinicians easily identify potential cases of NAFLD. While sonographic findings such as attenuation of image, diffuse echogenicity, uniform heterogeneous liver, thick subcutaneous depth, and enlarged liver filling of the entire field could be identified by clinicians from bedside ultrasound. The accessibility, ease of use, and low-side effect profile of ultrasound make bedside ultrasound an appealing imaging modality in the detection of hepatic steatosis. When used with appropriate clinical risk factors and steatosis involves greater than 33% of the liver, ultrasound can reliably diagnose NAFLD. Despite the ability of ultrasound in detecting moderate hepatic steatosis, it cannot replace liver biopsy in staging the degree of fibrosis. The purpose of this review is to examine the diagnostic accuracy, utility, and limitations of ultrasound in the diagnosis of NAFLD and its potential use by clinicians in routine practices.

KW - Bedside ultrasound

KW - Liver biopsy

KW - Liver cirrhosis

KW - Liver disease

KW - Liver fibrosis

KW - Non-alcoholic fatty liver disease

KW - Non-alcoholic steatohepatitis

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=84902192799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902192799&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i22.6821

DO - 10.3748/wjg.v20.i22.6821

M3 - Review article

C2 - 24944472

AN - SCOPUS:84902192799

VL - 20

SP - 6821

EP - 6825

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 22

ER -